Effect of therapy on motor cortical excitability in Parkinson's disease

Canadian Journal of Neurological Sciences

Volumn 35, Issue 2, 2008, Pages 166-172

  Soysal, Aysun ^a,b   Sobe, Ismail ^a   Atay, Turan ^a   Sen, Aysu ^a   Arpaci, Baki ^a  

^a Bakirkoy State Hospital for Psychiatric and Neurological Diseases   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE INHIBITOR;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; ELECTROMYOGRAM; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; FEMALE; HUMAN; MALE; MONOTHERAPY; MOTOR CORTEX; MOTOR NERVE CONDUCTION; MUSCLE ACTION POTENTIAL; MUSCLE CONTRACTION; NERVE CELL EXCITABILITY; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; TREATMENT OUTCOME;

EID: 45149126493     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100008581     Document Type: Article

References (27)

1. Priori A, Berardelli A, Inghilleri M, Accornero N, Manfredi M. Motor cortical inhibition and dopaminergic system. Pharmacological changes in the silent period after transcranial brain stimulation in normal subjects, patients with Parkinson's disease and drug-induced parkinsonism. Brain. 1994; 117: 317-23.
2. Young MS, Triggs WJ, Bowers D, Greer M, Friedman WA. Stereotactic pallidotomy lengthens the transcranial magnetic cortical stimulation silent period in Parkinson's disease. Neurology. 1997; 49: 1278-83.
3. Olanow CW, Jenner P, Tatton NA, Tatton WG. Neurodegeneration and Parkinson's disease. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Baltimore: Williams&Wilkins; 1993. p. 67-103.
4. Riley DE, Lang AE. Movement disorders. In: Bradley WG, Daroff RB, Fenichel GM, Marsden CD, editors. Neurology in clinical practice. The neurological diseases. Boston: Butterworth Heinemann; 2000. p. 1889-930.
5. Young AB, Penney JB. Biochemical and functional organization of the basal ganglia. In: Jankovic J, Tolosa E, editors. Parkinson's disease and movement disorders. Baltimore: Williams&Wilkins; 1993. p. 1-13.
6. Ridding MC, Inzelberg R, Rothwell JC. Changes in excitability of motor cortical circuitry in patients with Parkinson's disease. Ann Neurol. 1995; 37: 181-8.
7. Murray NMF. Motor evoked potentials In: Aminoff MJ, editor. Electrodiagnosis in clinical neurology. NewYork: Churchill Livingstone; 1992. p. 605-26.
8. Rossini PM, Barker AT, Berardelli A, Caramia MD, Caruso G, Cracco RQ, et al. Non-invazive electrical and magnetic stimulation of the brain, spinal cord and roots: basic principles and procedures for routine clinical application. Report of an IFCN committee. Electroenceph Clin Neurophysiol. 1994; 91: 79-92.
9. Cros D, Chiappa KH. Motor evoked potentials. In: Chiappa KH, editor. Evoked potentials in clinical medicine. Philadelphia: Lippincott-Raven Publishers; 1997. p. 477-507.
10. Rothwell JC, Hallett M, Berardelli A, Eisen A, Rossini P, Paulus W. Magnetic Stimulation: motor evoked potentials. In: Deuschl G, Eisen A, editors. Recommendations for the practice of clinical neurophysiology: Guidelines of the International Federation of Clinical Neurophysiology. Amsterdam: Elsevier Science B.V.; 1999. p. 97-103.
11. Robinson LR. Magnetic stimulation of the central and peripheral nervous systems. In: Dumitru D, Amato AA, editors. Electrodiagnostic medicine. Philadelphia: Hanley&Belfus, Inc.; 2002. p. 415-27.
12. Pascual-Leone A, Davey N, Rothwell J, Wassermann EM, Puri BK. editors. Handbook of transcranial magnetic stimulation. London: Arnold; 2002.
13. Weiner WJ, Lang AE. Rating scales for movement disorders. In: Weiner WJ, Lang AE, editors. Movement disorders. A comprehensive survey. Mount Kisko: Futura Publishing Company; 1989. p. 687-725.
14. Masur H. Scales and for specific syndromes and diseases. In: Masur H, editor. Scales and scores in neurology. Quantification of neurological deficits in research and practice. Stutgart: Thieme; 2004. p. 142-344.
15. Cantello R, Gianelli M, Bettucci D, Civardi C, De Angelis MS, Mutani R. Parkinson's disease rigidity: magnetic motor evoked potentials in a small hand muscle. Neurology. 1991; 41: 1449-56.
16. Uozumi T, Tsuji S, Murai Y. Motor potentials evoked by magnetic stimulation of the motor cortex in normal subjects and patients with motor disorders. Electroenceph Clin Neurophysiol. 1991; 81: 251-6.
17. Valls-Sole J, Pascual-Leone A, Brasil-Neto JP, Cammarota A, McShane L, Hallett M. Abnormal facilitation of the response to the transcranial magnetic stimulation in patients with Parkinson's disease. Neurology. 1994; 44: 735-41.
18. Valzania F, Strafella AP, Quatrale R, Santangelo M, Tropeani A. Lucchi D, et al. Motor evoked responses to paired cortical magnetic stimulation in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 1997; 105: 37-43.
19. Lou JS, Benice T, Kearns G, Sexton G, Nutt J. Levodopa normalizes exercise related cortico-motoneuron excitability abnormalities in Parkinson's disease. Clin Neurophysiol 2003; 114: 930-7.
20. Strafella AP, Valzania F, Nassetti SA, Tropeani A, Bisulli A, Santangelo M, et al. Effects of chronic levodopa and pergolide treatment on cortical excitability in patients with Parkinson's disease: a transcranial magnetic stimulation study. Clin Neurophysiol. 2000; 111: 1198-202.
21. Frasson E, Bertolasi L, Bertasi V, Fusina S, Bartolomei L, Vicentini S, et al. Paired transcranial magnetic stimulation for the early diagnosis of corticobasal degeneration. Clin Neurophysiol. 2003; 114: 272-8.
22. Chen R, Garg RR, Lozano AM, Lang AE. Effects of internal globus pallidus stimulation on motor cortex excitability. Neurology. 2001; 56: 716-23.
23. Dick JPR, Cowan JMA, Day BL, Berardelli A, Kachi T, Rothwell JC, et al. The corticomotoneurone connection is normal in Parkinson's disease. Nature. 1984; 310: 407-9.
24. De Rosa A, Volpe G, Marcantonio L, Santoro L, Brice A, Filla A, et al. Neurophysiological evidence of corticospinal tract abnormality in patients with Parkin mutations. J Neurol. 2006; 253: 275-9.
25. Guekht A, Selikhova M, Serkin G, Gusev E. Implementation of the TMS in early stages of Parkinson's diseases. Electromyogr Clin Neurophysiol. 2005; 45: 291-7.
26. Siebner HR, Mentschel C, Auer C, Lehner C, Conrad B. Repetitive transcranial magnetic stimulation causes a short-term increase in the duration of the cortical silent period in patients with Parkinson's disease. Neurosci Lett. 2000; 284: 147-50.
27. Berardelli A, Rona S, Inghilleri M, Manfredi M. Cortical inhibition in Parkinson's disease. A study with paired magnetic stimulation. Brain. 1996; 119: 71-7.